Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson Chairman and CEO Alex Gorsky takes the #EmbracingSustainability challenge
FINAL LEDE- Johnson & Johnson Chairman and CEO Alex Gorsky Takes the #EmbracingSustainability Challenge- Alex Gorsky hero

Johnson & Johnson Chairman and CEO Alex Gorsky takes the #EmbracingSustainability challenge

A new Business Roundtable campaign is challenging America’s top CEOs to shine a light on how they’re doing their part to help improve the health of the environment.

For more than 130 years, Johnson & Johnson has made it a mission to help keep people healthy. And since human health and environmental health are inextricably linked, the company is dedicated to helping keep the planet healthy, too.

Take its commitments to achieving the United Nations 2030 Sustainable Development Goals, its own Health for Humanity 2020 Goals and, most recently, Johnson & Johnson Consumer Inc.‘s decision to sign on as a charter member of the New Plastics Economy Global Commitment, which includes a pledge to use more recycled materials in its packaging.

It’s clear that sustainability is a top priority for Johnson & Johnson, which is why Chairman and CEO Alex Gorsky accepted an invitation this week from John Visentin, Vice Chairman and CEO of Xerox Corporation, to share just why it’s so important to the company as part of the new #EmbracingSustainability Challenge. The viral campaign was launched by Business Roundtable—an association of CEOs from America’s top companies—to show how corporate leaders are working to create a more environmentally, and economically, sustainable future.

In this video, Gorsky highlights just a few of the many ways Johnson & Johnson is doing just that—and passes the challenge baton to Chuck Robbins, Chairman and CEO of Cisco.


More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.